Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Gross Margin (2021 - 2025)

PAVmed (PAVM) has 5 years of Gross Margin data on record, last reported at 1000.0% in Q3 2025.

  • For Q3 2025, Gross Margin changed N/A year-over-year to 1000.0%; the TTM value through Sep 2025 reached 22510.34%, changed N/A, while the annual FY2024 figure was 61.6%, 55549.0% up from the prior year.
  • Gross Margin reached 1000.0% in Q3 2025 per PAVM's latest filing, down from 2916.67% in the prior quarter.
  • Across five years, Gross Margin topped out at 66420.0% in Q4 2024 and bottomed at 2987.5% in Q1 2025.
  • Average Gross Margin over 5 years is 4609.32%, with a median of 377.4% recorded in 2023.
  • Peak YoY movement for Gross Margin: tumbled -932656bps in 2023, then skyrocketed 6676709bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 2817.0% in 2021, then surged by 419bps to 8979.46% in 2022, then tumbled by -104bps to 347.09% in 2023, then soared by 19236bps to 66420.0% in 2024, then crashed by -102bps to 1000.0% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 1000.0% in Q3 2025, 2916.67% in Q2 2025, and 2987.5% in Q1 2025.